Self-tolerance, dendritic cell (DC)-mediated activation and tissue distribution of natural killer (NK) cells

Immunology Letters

Volumn 110, Issue 1, 2007, Pages 6-17

  Zanoni, Ivan ^a   Granucci, Francesca ^a   Foti, Maria ^a   Ricciardi Castagnoli, Paola ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Dendritic cells (DC); In vivo imaging; Natural killer (NK) cells; Self tolerance

Indexed keywords

GAMMA INTERFERON; NATURAL KILLER CELL RECEPTOR; TOLL LIKE RECEPTOR;

CELL ACTIVATION; CELL FUNCTION; CELL INTERACTION; CELL KILLING; CELL MATURATION; CELL MIGRATION; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; INTERFERON PRODUCTION; LYMPH NODE; LYMPHOID TISSUE; MAST CELL; MOLECULAR BIOLOGY; NATURAL KILLER T CELL; PHENOTYPE; PLASTICITY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TARGET CELL; TISSUE DISTRIBUTION;

ANIMALS; DENDRITIC CELLS; HUMANS; IMMUNITY, NATURAL; KILLER CELLS, NATURAL; SELF TOLERANCE;

EID: 34247577618     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2007.03.001     Document Type: Review

References (118)

1. Janeway Jr. C.A., and Medzhitov R. Innate immune recognition. Annu Rev Immunol 20 (2002) 197-216
2. Moretta A. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat Rev Immunol 2 (2002) 957-964
3. Takasugi M., Mickey M.R., and Terasaki P.I. Reactivity of lymphocytes from normal persons on cultured tumor cells. Cancer Res 33 (1973) 2898-2902
4. Kiessling R., Klein E., Pross H., and Wigzell H. "Natural" killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell. Eur J Immunol 5 (1975) 117-121
5. Kiessling R., Klein E., and Wigzell H. "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol 5 (1975) 112-117
6. Grimm E.A., Mazumder A., Zhang H.Z., and Rosenberg S.A. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J Exp Med 155 (1982) 1823-1841
7. Loza M.J., and Perussia B. Final steps of natural killer cell maturation: a model for type 1-type 2 differentiation?. Nat Immunol 2 (2001) 917-924
8. Orange J.S., and Ballas Z.K. Natural killer cells in human health and disease. Clin Immunol 118 (2006) 1-10
9. Moretta L., and Moretta A. Unravelling natural killer cell function: triggering and inhibitory human NK receptors. EMBO J 23 (2004) 255-259
10. Raulet D.H. Interplay of natural killer cells and their receptors with the adaptive immune response. Nat Immunol 5 (2004) 996-1002
11. Karre K. MHC gene control of the natural killer system at the level of the target and the host. Semin Cancer Biol 2 (1991) 295-309
12. Loza M.J., and Perussia B. Differential regulation of NK cell proliferation by type I and type II IFN. Int Immunol 16 (2004) 23-32
13. Ferlazzo G., Pack M., Thomas D., Paludan C., Schmid D., Strowig T., et al. Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc Natl Acad Sci USA 101 (2004) 16606-16611
14. Hayakawa Y., and Smyth M.J. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J Immunol 176 (2006) 1517-1524
15. Lanier L.L. NK cell recognition. Annu Rev Immunol 23 (2005) 225-274
16. Ljunggren H.G., and Karre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 11 (1990) 237-244
17. Long E.O. Regulation of immune responses through inhibitory receptors. Annu Rev Immunol 17 (1999) 875-904
18. Sivori S., Falco M., Della Chiesa M., Carlomagno S., Vitale M., Moretta L., et al. CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc Natl Acad Sci USA 101 (2004) 10116-10121
19. Schmidt K.N., Leung B., Kwong M., Zarember K.A., Satyal S., Navas T.A., et al. APC-independent activation of NK cells by the Toll-like receptor 3 agonist double-stranded RNA. J Immunol 172 (2004) 138-143
20. Pisegna S., Pirozzi G., Piccoli M., Frati L., Santoni A., and Palmieri G. p38 MAPK activation controls the TLR3-mediated up-regulation of cytotoxicity and cytokine production in human NK cells. Blood 104 (2004) 4157-4164
21. Raulet D.H., Vance R.E., and McMahon C.W. Regulation of the natural killer cell receptor repertoire. Annu Rev Immunol 19 (2001) 291-330
22. Grigoriadou K., Menard C., Perarnau B., and Lemonnier F.A. MHC class Ia molecules alone control NK-mediated bone marrow graft rejection. Eur J Immunol 29 (1999) 3683-3690
23. Ogasawara K., Benjamin J., Takaki R., Phillips J.H., and Lanier L.L. Function of NKG2D in natural killer cell-mediated rejection of mouse bone marrow grafts. Nat Immunol 6 (2005) 938-945
24. George T.C., Ortaldo J.R., Lemieux S., Kumar V., and Bennett M. Tolerance and alloreactivity of the Ly49D subset of murine NK cells. J Immunol 163 (1999) 1859-1867
25. Valiante N.M., Uhrberg M., Shilling H.G., Lienert-Weidenbach K., Arnett K.L., D'Andrea A., et al. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 7 (1997) 739-751
26. Liao N.S., Bix M., Zijlstra M., Jaenisch R., and Raulet D. MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. Science 253 (1991) 199-202
27. Fernandez N.C., Treiner E., Vance R.E., Jamieson A.M., Lemieux S., and Raulet D.H. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 105 (2005) 4416-4423
28. Kim S., Poursine-Laurent J., Truscott S.M., Lybarger L., Song Y.J., Yang L., et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436 (2005) 709-713
29. Yokoyama W.M., and Kim S. How do natural killer cells find self to achieve tolerance?. Immunity 24 (2006) 249-257
30. Raulet D.H., and Vance R.E. Self-tolerance of natural killer cells. Nat Rev Immunol 6 (2006) 520-531
31. Dokun A.O., Kim S., Smith H.R., Kang H.S., Chu D.T., and Yokoyama W.M. Specific and nonspecific NK cell activation during virus infection. Nat Immunol 2 (2001) 951-956
32. Yokoyama W.M., and Kim S. Licensing of natural killer cells by self-major histocompatibility complex class I. Immunol Rev 214 (2006) 143-154
33. Andrews D.M., Scalzo A.A., Yokoyama W.M., Smyth M.J., and Degli-Esposti M.A. Functional interactions between dendritic cells and NK cells during viral infection. Nat Immunol 4 (2003) 175-181
34. Ferlazzo G., Tsang M.L., Moretta L., Melioli G., Steinman R.M., and Munz C. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med 195 (2002) 343-351
35. Fernandez N.C., Lozier A., Flament C., Ricciardi-Castagnoli P., Bellet D., Suter M., et al. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med 5 (1999) 405-411
36. Gerosa F., Baldani-Guerra B., Nisii C., Marchesini V., Carra G., and Trinchieri G. Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med 195 (2002) 327-333
37. Granucci F., Zanoni I., Pavelka N., Van Dommelen S.L., Andoniou C.E., Belardelli F., et al. A contribution of mouse dendritic cell-derived IL-2 for NK cell activation. J Exp Med 200 (2004) 287-295
38. Zanoni I., Foti M., Ricciardi-Castagnoli P., and Granucci F. TLR-dependent activation stimuli associated with Th1 responses confer NK cell stimulatory capacity to mouse dendritic cells. J Immunol 175 (2005) 286-292
39. Smyth M.J., Hayakawa Y., Takeda K., and Yagita H. New aspects of natural-killer-cell surveillance and therapy of cancer. Nat Rev Cancer 2 (2002) 850-861
40. Moretta A. The dialogue between human natural killer cells and dendritic cells. Curr Opin Immunol 17 (2005) 306-311
41. Piccioli D., Sbrana S., Melandri E., and Valiante N.M. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J Exp Med 195 (2002) 335-341
42. Zitvogel L. Dendritic and natural killer cells cooperate in the control/switch of innate immunity. J Exp Med 195 (2002) F9-F14
43. Steinman R.M. Dendritic cells and the control of immunity: enhancing the efficiency of antigen presentation. Mt Sinai J Med 68 (2001) 106-166
44. Granucci F., Vizzardelli C., Virzi E., Rescigno M., and Ricciardi-Castagnoli P. Transcriptional reprogramming of dendritic cells by differentiation stimuli. Eur J Immunol 31 (2001) 2539-2546
45. Ardavin C. Origin, precursors and differentiation of mouse dendritic cells. Nat Rev Immunol 3 (2003) 582-590
46. Ardavin C., Martinez del Hoyo G., Martin P., Anjuere F., Arias C.F., Marin A.R., et al. Origin and differentiation of dendritic cells. Trends Immunol 22 (2001) 691-700
47. Shortman K., and Liu Y.J. Mouse and human dendritic cell subtypes. Nat Rev Immunol 2 (2002) 151-161
48. Henri S., Vremec D., Kamath A., Waithman J., Williams S., Benoist C., et al. The dendritic cell populations of mouse lymph nodes. J Immunol 167 (2001) 741-748
49. Anjuere F., Martin P., Ferrero I., Fraga M.L., del Hoyo G.M., Wright N., et al. Definition of dendritic cell subpopulations present in the spleen, Peyer's patches, lymph nodes, and skin of the mouse. Blood 93 (1999) 590-598
50. Asselin-Paturel C., Boonstra A., Dalod M., Durand I., Yessaad N., Dezutter-Dambuyant C., et al. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat Immunol 2 (2001) 1144-1150
51. Kadowaki N., and Liu Y.J. Natural type I interferon-producing cells as a link between innate and adaptive immunity. Hum Immunol 63 (2002) 1126-1132
52. Rescigno M., Citterio S., Thery C., Rittig M., Medaglini D., Pozzi G., et al. Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells. Proc Natl Acad Sci USA 95 (1998) 5229-5234
53. Corinti S., Medaglini D., Cavani A., Rescigno M., Pozzi G., Ricciardi-Castagnoli P., et al. Human dendritic cells very efficiently present a heterologous antigen expressed on the surface of recombinant gram-positive bacteria to CD4+ T lymphocytes. J Immunol 163 (1999) 3029-3036
54. Granucci F., Vizzardelli C., Pavelka N., Feau S., Persico M., Virzi E., et al. Inducible IL-2 production by dendritic cells revealed by global gene expression analysis. Nat Immunol 2 (2001) 882-888
55. Granucci F., Feau S., Angeli V., Trottein F., and Ricciardi-Castagnoli P. Early IL-2 production by mouse dendritic cells is the result of microbial-induced priming. J Immunol 170 (2003) 5075-5081
56. Feau S., Facchinetti V., Granucci F., Citterio S., Jarrossay D., Seresini S., et al. Dendritic cell-derived IL-2 production is regulated by IL-15 in humans and in mice. Blood 105 (2005) 697-702
57. Kassim S.H., Rajasagi N.K., Zhao X., Chervenak R., and Jennings S.R. In vivo ablation of CD11c-positive dendritic cells increases susceptibility to herpes simplex virus type 1 infection and diminishes NK and T-cell responses. J Virol 80 (2006) 3985-3993
58. Gerosa F., Gobbi A., Zorzi P., Burg S., Briere F., Carra G., et al. The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions. J Immunol 174 (2005) 727-734
59. Dalod M., Hamilton T., Salomon R., Salazar-Mather T.P., Henry S.C., Hamilton J.D., et al. Dendritic cell responses to early murine cytomegalovirus infection: subset functional specialization and differential regulation by interferon α/β. J Exp Med 197 (2003) 885-898
60. Nguyen K.B., Salazar-Mather T.P., Dalod M.Y., Van Deusen J.B., Wei X.Q., Liew F.Y., et al. Coordinated and distinct roles for IFN-αβ, IL-12, and IL-15 regulation of NK cell responses to viral infection. J Immunol 169 (2002) 4279-4287
61. Moretta L., Ferlazzo G., Bottino C., Vitale M., Pende D., Mingari M.C., et al. Effector and regulatory events during natural killer-dendritic cell interactions. Immunol Rev 214 (2006) 219-228
62. Amakata Y., Fujiyama Y., Andoh A., Hodohara K., and Bamba T. Mechanism of NK cell activation induced by coculture with dendritic cells derived from peripheral blood monocytes. Clin Exp Immunol 124 (2001) 214-222
63. Ferlazzo G., Morandi B., D'Agostino A., Meazza R., Melioli G., Moretta A., et al. The interaction between NK cells and dendritic cells in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells. Eur J Immunol 33 (2003) 306-313
64. Kikuchi T., Hahn C.L., Tanaka S., Barbour S.E., Schenkein H.A., and Tew J.G. Dendritic cells stimulated with Actinobacillus actinomycetemcomitans elicit rapid gamma interferon responses by natural killer cells. Infect Immun 72 (2004) 5089-5096
65. Alli R.S., and Khar A. Interleukin-12 secreted by mature dendritic cells mediates activation of NK cell function. FEBS Lett 559 (2004) 71-76
66. Borg C., Jalil A., Laderach D., Maruyama K., Wakasugi H., Charrier S., et al. NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs. Blood 104 (2004) 3267-3275
67. Kamath A.T., Sheasby C.E., and Tough D.F. Dendritic cells and NK cells stimulate bystander T cell activation in response to TLR agonists through secretion of IFN-αβ and IFN-γ. J Immunol 174 (2005) 767-776
68. Koka R., Burkett P., Chien M., Chai S., Boone D.L., and Ma A. Cutting edge: murine dendritic cells require IL-15R alpha to prime NK cells. J Immunol 173 (2004) 3594-3598
69. Mailliard R.B., Alber S.M., Shen H., Watkins S.C., Kirkwood J.M., Herberman R.B., et al. IL-18-induced CD83+CCR7+ NK helper cells. J Exp Med 202 (2005) 941-953
70. Munz C., Dao T., Ferlazzo G., de Cos M.A., Goodman K., and Young J.W. Mature myeloid dendritic cell subsets have distinct roles for activation and viability of circulating human natural killer cells. Blood 105 (2005) 266-273
71. Osada T., Nagawa H., Kitayama J., Tsuno N.H., Ishihara S., Takamizawa M., et al. Peripheral blood dendritic cells, but not monocyte-derived dendritic cells, can augment human NK cell function. Cell Immunol 213 (2001) 14-23
72. Vitale M., Della Chiesa M., Carlomagno S., Romagnani C., Thiel A., Moretta L., et al. The small subset of CD56brightCD16- natural killer cells is selectively responsible for both cell proliferation and interferon-γ production upon interaction with dendritic cells. Eur J Immunol 34 (2004) 1715-1722
73. Yu Y., Hagihara M., Ando K., Gansuvd B., Matsuzawa H., Tsuchiya T., et al. Enhancement of human cord blood CD34+ cell-derived NK cell cytotoxicity by dendritic cells. J Immunol 166 (2001) 1590-1600
74. Newman K.C., Korbel D.S., Hafalla J.C., and Riley E.M. Cross-talk with myeloid accessory cells regulates human natural killer cell interferon-γ responses to malaria. PLoS Pathog 2 (2006) e118
75. Xu J., Chakrabarti A.K., Tan J.L., Ge L., Gambotto A., and Vujanovic N.L. Essential role of the TNF-TNFR2 cognate interaction in mouse dendritic cell-natural killer cell cross-talk. Blood (2006) Publish ahead of print
76. Biron C.A., Nguyen K.B., Pien G.C., Cousens L.P., and Salazar-Mather T.P. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 17 (1999) 189-220
77. Hochrein H., O'Keeffe M., Luft T., Vandenabeele S., Grumont R.J., Maraskovsky E., et al. Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells. J Exp Med 192 (2000) 823-833
78. Terme M., Tomasello E., Maruyama K., Crepineau F., Chaput N., Flament C., et al. IL-4 confers NK stimulatory capacity to murine dendritic cells: a signaling pathway involving KARAP/DAP12-triggering receptor expressed on myeloid cell 2 molecules. J Immunol 172 (2004) 5957-5966
79. Guiducci C., Valzasina B., Dislich H., and Colombo M.P. CD40/CD40L interaction regulates CD4(+)CD25(+) T reg homeostasis through dendritic cell-produced IL-2. Eur J Immunol 35 (2005) 557-567
80. Zitvogel L., Fernandez N., Lozier A., Wolfers J., Regnault A., Raposo G., et al. Dendritic cells or their exosomes are effective biotherapies of cancer. Eur J Cancer 35 Suppl 3 (1999) S36-S38
81. Van Den Broeke L.T., Daschbach E., Thomas E.K., Andringa G., and Berzofsky J.A. Dendritic cell-induced activation of adaptive and innate antitumor immunity. J Immunol 171 (2003) 5842-5852
82. Vitale M., Della Chiesa M., Carlomagno S., Pende D., Arico M., Moretta L., et al. NK-dependent DC maturation is mediated by TNFα and IFNγ released upon engagement of the NKp30 triggering receptor. Blood 106 (2005) 566-571
83. Tosi D., Valenti R., Cova A., Sovena G., Huber V., Pilla L., et al. Role of cross-talk between IFN-α-induced monocyte-derived dendritic cells and NK cells in priming CD8+ T cell responses against human tumor antigens. J Immunol 172 (2004) 5363-5370
84. Semino C., Angelini G., Poggi A., and Rubartelli A. NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1. Blood 106 (2005) 609-616
85. Semino C., Ceccarelli J., Lotti L.V., Torrisi M.R., Angelini G., and Rubartelli A. The maturation potential of NK cell clones toward autologous dendritic cells correlates with HMGB1 secretion. J Leukoc Biol 81 (2007) 92-99
86. Pan P.Y., Gu P., Li Q., Xu D., Weber K., and Chen S.H. Regulation of dendritic cell function by NK cells: mechanisms underlying the synergism in the combination therapy of IL-12 and 4-1BB activation. J Immunol 172 (2004) 4779-4789
87. Carbone E., Terrazzano G., Ruggiero G., Zanzi D., Ottaiano A., Manzo C., et al. Recognition of autologous dendritic cells by human NK cells. Eur J Immunol 29 (1999) 4022-4029
88. Ferlazzo G., Semino C., and Melioli G. HLA class I molecule expression is up-regulated during maturation of dendritic cells, protecting them from natural killer cell-mediated lysis. Immunol Lett 76 (2001) 37-41
89. Pende D., Castriconi R., Romagnani P., Spaggiari G.M., Marcenaro S., Dondero A., et al. Expression of the DNAM-1 ligands Nectin-2 (CD112) and poliovirus receptor (CD155) on dendritic cells: relevance for natural killer/dendritic cells interaction. Blood 107 (2006) 2030-2036
90. Qian C., Jiang X., An H., Yu Y., Guo Z., Liu S., et al. TLR agonists promote ERK-mediated preferential IL-10 production of regulatory dendritic cells (diffDCs), leading to NK-cell activation. Blood 108 (2006) 2307-2315
91. Hayakawa Y., Screpanti V., Yagita H., Grandien A., Ljunggren H.G., Smyth M.J., et al. NK cell TRAIL eliminates immature dendritic cells in vivo and limits dendritic cell vaccination efficacy. J Immunol 172 (2004) 123-129
92. Becker I., Salaiza N., Aguirre M., Delgado J., Carrillo-Carrasco N., Kobeh L.G., et al. Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2. Mol Biochem Parasitol 130 (2003) 65-74
93. Chalifour A., Jeannin P., Gauchat J.F., Blaecke A., Malissard M., N'Guyen T., et al. Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers alpha-defensin production. Blood 104 (2004) 1778-1783
94. Hart O.M., Athie-Morales V., O'Connor G.M., and Gardiner C.M. TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-γ production. J Immunol 175 (2005) 1636-1642
95. Tsujimoto H., Uchida T., Efron P.A., Scumpia P.O., Verma A., Matsumoto T., et al. Flagellin enhances NK cell proliferation and activation directly and through dendritic cell-NK cell interactions. J Leukoc Biol 78 (2005) 888-897
96. Krug A., French A.R., Barchet W., Fischer J.A., Dzionek A., Pingel J.T., et al. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 21 (2004) 107-119
97. Marshall J.D., Heeke D.S., Abbate C., Yee P., and Van Nest G. Induction of interferon-γ from natural killer cells by immunostimulatory CpG DNA is mediated through plasmacytoid-dendritic-cell-produced interferon-alpha and tumour necrosis factor-alpha. Immunology 117 (2006) 38-46
98. Marshall J.S. Mast-cell responses to pathogens. Nat Rev Immunol 4 (2004) 787-799
99. Kulka M., Alexopoulou L., Flavell R.A., and Metcalfe D.D. Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3. J Allergy Clin Immunol 114 (2004) 174-182
100. Supajatura V., Ushio H., Nakao A., Akira S., Okumura K., Ra C., et al. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J Clin Invest 109 (2002) 1351-1359
101. Marcenaro E., Della Chiesa M., Bellora F., Parolini S., Millo R., Moretta L., et al. IL-12 or IL-4 prime human NK cells to mediate functionally divergent interactions with dendritic cells or tumors. J Immunol 174 (2005) 3992-3998
102. Andrews D.M., Farrell H.E., Densley E.H., Scalzo A.A., Shellam G.R., and Degli-Esposti M.A. NK1.1+ cells and murine cytomegalovirus infection: what happens in situ?. J Immunol 166 (2001) 1796-1802
103. Cooper M.A., Fehniger T.A., Fuchs A., Colonna M., and Caligiuri M.A. NK cell and DC interactions. Trends Immunol 25 (2004) 47-52
104. Frey M., Packianathan N.B., Fehniger T.A., Ross M.E., Wang W.C., Stewart C.C., et al. Differential expression and function of L-selectin on CD56bright and CD56dim natural killer cell subsets. J Immunol 161 (1998) 400-408
105. Fehniger T.A., Cooper M.A., Nuovo G.J., Cella M., Facchetti F., Colonna M., et al. CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood 101 (2003) 3052-3057
106. Ferlazzo G., Thomas D., Lin S.L., Goodman K., Morandi B., Muller W.A., et al. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J Immunol 172 (2004) 1455-1462
107. Martin-Fontecha A., Thomsen L.L., Brett S., Gerard C., Lipp M., Lanzavecchia A., et al. Induced recruitment of NK cells to lymph nodes provides IFN-γ for T(H)1 priming. Nat Immunol 5 (2004) 1260-1265
108. Bajenoff M., Breart B., Huang A.Y., Qi H., Cazareth J., Braud V.M., et al. Natural killer cell behavior in lymph nodes revealed by static and real-time imaging. J Exp Med 203 (2006) 619-631
109. Byrne P., McGuirk P., Todryk S., and Mills K.H. Depletion of NK cells results in disseminating lethal infection with Bordetella pertussis associated with a reduction of antigen-specific Th1 and enhancement of Th2, but not Tr1 cells. Eur J Immunol 34 (2004) 2579-2588
110. Cooper M.A., Fehniger T.A., Turner S.C., Chen K.S., Ghaheri B.A., Ghayur T., et al. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood 97 (2001) 3146-3151
111. Mailliard R.B., Son Y.I., Redlinger R., Coates P.T., Giermasz A., Morel P.A., et al. Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function. J Immunol 171 (2003) 2366-2373
112. Wald O., Weiss I.D., Wald H., Shoham H., Bar-Shavit Y., Beider K., et al. IFN-γ acts on T cells to induce NK cell mobilization and accumulation in target organs. J Immunol 176 (2006) 4716-4729
113. Gazit R., Gruda R., Elboim M., Arnon T.I., Katz G., Achdout H., et al. Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat Immunol 7 (2006) 517-523
114. Jiang D., Liang J., Hodge J., Lu B., Zhu Z., Yu S., et al. Regulation of pulmonary fibrosis by chemokine receptor CXCR3. J Clin Invest 114 (2004) 291-299
115. Salazar-Mather T.P., Lewis C.A., and Biron C.A. Type I interferons regulate inflammatory cell trafficking and macrophage inflammatory protein 1alpha delivery to the liver. J Clin Invest 110 (2002) 321-330
116. Salazar-Mather T.P., Orange J.S., and Biron C.A. Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1alpha (MIP-1alpha)-dependent pathways. J Exp Med 187 (1998) 1-14
117. Khan I.A., Thomas S.Y., Moretto M.M., Lee F.S., Islam S.A., Combe C., et al. CCR5 is essential for NK cell trafficking and host survival following Toxoplasma gondii infection. PLoS Pathog 2 (2006) e49
118. Parolini S., Santoro A., Marcenaro E., Luini W., Massardi L., Facchetti F., et al. The role of chemerin in the co-localization of NK and dendritic cell subsets into inflamed tissues. Blood (2007) Publish ahead of print